Biotech GPRC5D-directed Therapies Market is Anticipated to Gain Momentum During the Forecast Period (2025-2034) Owing to Unmet Need in Multiple Myeloma | DelveInsight July 4, 2025
Biotech Pond Technologies Holdings Inc. Announces Filing of 2025 First Quarter Unaudited Condensed Interim Financial Statements and MD&A July 1, 2025
Biotech Hansa Biopharma presents positive outcomes of five-year follow-up study of imlifidase in kidney transplantation at ESOT Congress 2025 in London June 30, 2025
Biotech ESOT Congress 2025: Scientists create functional human islets in 3D printing breakthrough for type 1 diabetes treatment June 29, 2025
Biotech Challenge accepted: New funding for ambitious projects within biomanufacturing, cardiometabolic diseases, and artificial intelligence June 27, 2025
Biotech Edgewise Therapeutics Reports Positive Results on Sevasemten Program for Becker and Duchenne Muscular Dystrophies June 26, 2025